ANTERIX INC (ATEX)

US03676C1009 - Common Stock

33.61  +0.05 (+0.15%)

After market: 33.61 0 (0%)

Fundamental Rating

4

ATEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Diversified Telecommunication Services industry. No worries on liquidiy or solvency for ATEX as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, ATEX is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

ATEX had positive earnings in the past year.
ATEX had a positive operating cash flow in the past year.
In the past 5 years ATEX always reported negative net income.
In the past 5 years ATEX reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of ATEX (4.93%) is better than 88.89% of its industry peers.
With a decent Return On Equity value of 9.18%, ATEX is doing good in the industry, outperforming 72.22% of the companies in the same industry.
Industry RankSector Rank
ROA 4.93%
ROE 9.18%
ROIC N/A
ROA(3y)-13.62%
ROA(5y)-15.25%
ROE(3y)-18.28%
ROE(5y)-18.68%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of ATEX (446.71%) is better than 100.00% of its industry peers.
ATEX has a Gross Margin of 54.22%. This is comparable to the rest of the industry: ATEX outperforms 47.22% of its industry peers.
ATEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 446.71%
GM 54.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.66%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEX has more shares outstanding
ATEX has more shares outstanding than it did 5 years ago.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ATEX has an Altman-Z score of 0.64. This is a bad value and indicates that ATEX is not financially healthy and even has some risk of bankruptcy.
ATEX's Altman-Z score of 0.64 is in line compared to the rest of the industry. ATEX outperforms 41.67% of its industry peers.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.64
ROIC/WACCN/A
WACC8.84%

2.3 Liquidity

A Current Ratio of 4.51 indicates that ATEX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.51, ATEX belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
A Quick Ratio of 4.51 indicates that ATEX has no problem at all paying its short term obligations.
ATEX has a Quick ratio of 4.51. This is amongst the best in the industry. ATEX outperforms 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 4.51

6

3. Growth

3.1 Past

ATEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 120.08%, which is quite impressive.
ATEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 113.31%.
The Revenue for ATEX have been decreasing by -21.30% on average. This is quite bad
EPS 1Y (TTM)120.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q104.76%
Revenue 1Y (TTM)113.31%
Revenue growth 3Y7.17%
Revenue growth 5Y-21.3%
Revenue growth Q2Q119.14%

3.2 Future

The Earnings Per Share is expected to grow by 35.37% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 223.76% on average over the next years. This is a very strong growth
EPS Next Y64.24%
EPS Next 2Y-60.12%
EPS Next 3Y35.37%
EPS Next 5YN/A
Revenue Next Year116.5%
Revenue Next 2Y151.1%
Revenue Next 3Y223.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

ATEX is valuated quite expensively with a Price/Earnings ratio of 73.07.
ATEX's Price/Earnings is on the same level as the industry average.
ATEX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.48.
ATEX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 73.07
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ATEX is valued a bit more expensive than 61.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 109.45
EV/EBITDA N/A

4.3 Compensation for Growth

ATEX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ATEX's earnings are expected to grow with 35.37% in the coming years.
PEG (NY)1.14
PEG (5Y)N/A
EPS Next 2Y-60.12%
EPS Next 3Y35.37%

0

5. Dividend

5.1 Amount

ATEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ANTERIX INC

NASDAQ:ATEX (3/28/2024, 8:00:01 PM)

After market: 33.61 0 (0%)

33.61

+0.05 (+0.15%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap622.46M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 73.07
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 9.18%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 446.71%
GM 54.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.51
Quick Ratio 4.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)120.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y64.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)113.31%
Revenue growth 3Y7.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y